Reactivity of 2-nitroxysuccinate 3-hydroxy-6-methyl-2-ethylpyridine and reference drugs in model NO-generating systems

Cover Page

Cite item

Full Text

Abstract

The ability of the 2-nitroxysuccinate 3-hydroxy-6-methyl-2-ethylpyridine (I) compound to generate nitrite ions (NO2) and nitrogen monoxide (NO) in model systems with cysteine (Cys) and deoxyhemoglobin (Hb) has been studied. It has been established that there is a more efficient release NO2 and NO from compound I than from Nicorandil. The accumulation rate is 1.5 times higher in the system of Cys with I than with Nitroglycerin. It is shown that, unlike Nitroglycerin, compound I is not reduced by Hb.

About the authors

O. V. Pokidova

Institute of Problem of Chemical Physics of the Russian Academy of Science

Author for correspondence.
Email: pov@icp.ac.ru
Russian Federation, 1, Acad. Semenov av., Chernogolovka, Moscow region, 142432

E. V. Batova

Ivanovo State University

Email: pov@icp.ac.ru
Russian Federation, 39, Ermaka street, Ivanovo, 153025

A. P. Sadkov

Institute of Problem of Chemical Physics of the Russian Academy of Science

Email: pov@icp.ac.ru
Russian Federation, 1, Acad. Semenov av., Chernogolovka, Moscow region, 142432

A. B. Eremeev

Institute of Problem of Chemical Physics of the Russian Academy of Science

Email: pov@icp.ac.ru
Russian Federation, 1, Acad. Semenov av., Chernogolovka, Moscow region, 142432

B. S. Fedorov

Institute of Problem of Chemical Physics of the Russian Academy of Science

Email: pov@icp.ac.ru
Russian Federation, 1, Acad. Semenov av., Chernogolovka, Moscow region, 142432

A. I. Kotelnikov

Institute of Problem of Chemical Physics of the Russian Academy of Science; Lomonosov Moscow State University

Email: pov@icp.ac.ru
Russian Federation, 1, Acad. Semenov av., Chernogolovka, Moscow region, 142432; 1, Leninskie gory, Moscow, 119991

References

  1. Wang P.G., Cai T.B. Taniguchi N. Nitric Oxide Donors: for Pharmaceutical and Biological Applications. Weinheim: Wiley-VCH Verlag, 2005. 360 p.
  2. Page N.A., Fung H.L. // J. Pharm. Sci. 2013. V. 102. № 9. P. 3070-3081.
  3. Ignarro L.J. Nitric Oxide Biology and Pathobiology. San Diego.: Acad. Press, 2000. 1003 p.
  4. RU Pat. 2250210 2010.
  5. Неганова М.Е., Клочкова С.Г., Шевцова Е.Ф., Богатыренко Т.Н., Мищенко Д.В. // БЭБиМ. 2018. T. 166. № 7. P. 53-57.
  6. Татьяненко Л.В., Доброхотова О.В., Варфоломеев В.Н., Фадеев М.А., Федоров Б.С., Штолько В.Н., Мищенко Д.В. // Хим.-фарм. журн. 2014. T. 48. № 7. С. 3-6.
  7. Feelisch M. // J. Cardiovasc. Pharmacol. 1991. V. 17. № Suppl. 3. P. S25-S33.
  8. Yeates R.A., Laufen H., Leitold M. // Mol. Pharmacol. 1985. V. 28. P. 555-559.
  9. Fox J.B. // Anal. Chem. 1979. V. 51. № 9. P. 1493-1502.
  10. Huang Z., Shiva S., Kim-Shapiro D.B., Patel R.P. // J. Clin. Invest. 2005. V. 11. № 8. P. 2099-2107.
  11. Bennett B.M., Nakatsu K., Brein J.F., Marks G.S. // Canad. J. Physiol. Pharmacol. 1984. V. 62. № 6. P. 704-706.
  12. Antonini E., Brunori M. Hemoglobin and Myoglobin in the Reactions with Ligands, in: North-Holland Research Monographs. Frontiers of Biology. Amsterdam; L., North-Holland Publ., 1971. V. 21. 436 p.
  13. Geraci G., Parkhurst L.J., Gibson Q.H. // J. Biol. Chem. 1969. V. 244. № . 17. P. 4664-4667.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Russian academy of sciences

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies